FOLFIRINOX-Based Neoadjuvant Therapy in Borderline Resectable or Unresectable Pancreatic Cancer

Authors

Keywords

Journal

Volume 44, Issue 4, Pages 515-521

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2015-04-15

DOI

10.1097/mpa.0000000000000314

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started